TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Enorama Pharma AB
Closing information (x1000 SEK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
15,768
|
1,358
|
6,847 |
| Financial expenses |
2,990
|
3,589
|
2,088 |
| Earnings before taxes |
-43,806
|
-44,613
|
-42,030 |
| EBITDA |
-27,105
|
-38,579
|
-37,933 |
| Total assets |
15,894
|
34,385
|
48,721 |
| Current assets |
15,160
|
12,964
|
11,752 |
| Current liabilities |
8,091
|
10,218
|
12,426 |
| Equity capital |
7,803
|
19,538
|
31,524 |
| - share capital |
9,449
|
6,394
|
1,461 |
| Employees (average) |
5
|
5
|
9 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
49.1%
|
56.8%
|
64.7% |
| Turnover per employee |
3,154
|
272
|
761 |
| Profit as a percentage of turnover |
-277.8%
|
-3285.2%
|
-613.8% |
| Return on assets (ROA) |
-256.8%
|
-119.3%
|
-82.0% |
| Current ratio |
187.4%
|
126.9%
|
94.6% |
| Return on equity (ROE) |
-561.4%
|
-228.3%
|
-133.3% |
| Change turnover |
14,410
|
-5,489
|
-4,189 |
| Change turnover % |
1061%
|
-80%
|
-38% |
| Chg. No. of employees |
0
|
-4
|
-1 |
| Chg. No. of employees % |
0%
|
-44%
|
-10% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.